Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Jun;13(3):205–207. doi: 10.1080/09511920410001713484

Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression.

Rosaria Alba Merendino 1, Giuseppe Di Pasquale 1, Filippo De Luca 1, Laura Di Pasquale 1, Edoardo Ferlazzo 1, Gabriella Martino 1, Maura Carmela Palumbo 1, Fortunato Morabito 1, Sebastiano Gangemi 1
PMCID: PMC1781561  PMID: 15223613

Abstract

Moderate-severe depression (MSD) is linked to overexpression of proinflammatory cytokines and chemokines. Fractalkine (FKN) and macrophage inflammatory protein-1 alpha (MIP-1alpha) are, respectively, members of CX3C and C-C chemokines, and both are involved in recruiting and activating mononuclear phagocytes in the central nervous system. We analysed the presence of FKN and MIP-1alpha in sera of untreated MSD patients and healthy donors. High FKN levels were observed in all MSD patients as compared with values only detectable in 26% of healthy donors. MIP-1alpha was measurable in 20% of patients, while no healthy donors showed detectable chemokine levels. In conclusion, we describe a previously unknown involvement of FKN in the pathogenesis of MSD, suggesting that FKN may represent a target for a specific immune therapy of this disease.

Full Text

The Full Text of this article is available as a PDF (63.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajetto Adriana, Bonavia Rudy, Barbero Simone, Schettini Gennaro. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem. 2002 Sep;82(6):1311–1329. doi: 10.1046/j.1471-4159.2002.01091.x. [DOI] [PubMed] [Google Scholar]
  2. Fraticelli P., Sironi M., Bianchi G., D'Ambrosio D., Albanesi C., Stoppacciaro A., Chieppa M., Allavena P., Ruco L., Girolomoni G. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest. 2001 May;107(9):1173–1181. doi: 10.1172/JCI11517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Merendino Rosaria Alba, Di Rosa Antonio Enrico, Di Pasquale Giuseppe, Minciullo Paola Lucia, Mangraviti Carmela, Costantino Antonella, Ruello Antonella, Gangemi Sebastiano. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm. 2002 Aug;11(4):265–267. doi: 10.1080/096293502900000131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Nunes S. O. V., Reiche E. M. V., Morimoto H. K., Matsuo T., Itano E. N., Xavier E. C. D., Yamashita C. M., Vieira V. R., Menoli A. V., Silva S. S. Immune and hormonal activity in adults suffering from depression. Braz J Med Biol Res. 2002 May;35(5):581–587. doi: 10.1590/s0100-879x2002000500011. [DOI] [PubMed] [Google Scholar]
  5. Suarez Edward C., Krishnan Ranga R., Lewis James G. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med. 2003 May-Jun;65(3):362–368. doi: 10.1097/01.psy.0000035719.79068.2b. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES